MOUNTAIN VIEW, Calif., Feb. 27, 2013 /PRNewswire/ -- Fewer breast imaging facilities in the United States, in addition to ongoing controversies surrounding breast cancer screening, has suppressed growth in the U.S. breast imaging systems market. However, Frost & Sullivan anticipates modest expansion, driven by the increasing demand for breast imaging equipment due to the growing prevalence of breast cancer, as well as increases in breast cancer surgery procedure volumes and supplemental screening exams prompted by new breast density reporting legislation.
New analysis from Frost & Sullivan's (http://www.medicalimaging.frost.com) Analysis of the U.S. Breast Imaging Systems Market research finds that the market earned revenues of $1.0 billion in 2011 and expects this to reach $1.4 billion by 2016 at a compound annual growth rate (CAGR) of 5.8 percent. The anticipated growth is due to growing revenues in the X-ray mammography, breast ultrasound, breast magnetic resonance imaging (MRI), and molecular breast imaging (MBI) market segments.
If you are interested in more information on this research, please email Britni Myers , Corporate Communications, at firstname.lastname@example.org, with your full name, company name, job title, telephone number, company email address, company website, city, state and country.
A key factor restraining market growth is consolidation of the breast imaging provider market, which has led to a smaller number of facilities in the United States. In addition, conflicting recommendations regarding the age at which mammography screening should begin has
|SOURCE Frost & Sullivan|
Copyright©2012 PR Newswire.
All rights reserved